Panagora Asset Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1
Closed 2631
2019
Q4
$0 Sell
1
-17
-94% -$1.97K ﹤0.01% 2606
2019
Q3
$3K Sell
18
-498
-97% -$114K ﹤0.01% 2356
2019
Q2
$138K Sell
516
-1
-0.2% -$335 ﹤0.01% 1891
2019
Q1
$196K Hold
517
﹤0.01% 1716
2018
Q4
$192K Buy
517
+1
+0.2% +$392 ﹤0.01% 1624
2018
Q3
$223K Sell
516
-85
-14% -$35.8K ﹤0.01% 1639
2018
Q2
$218K Buy
601
+579
+2,632% +$273K ﹤0.01% 1630
2018
Q1
$10K Hold
22
﹤0.01% 2262
2017
Q4
$13K Sell
22
-1
-4% -$659 ﹤0.01% 2208
2017
Q3
$17K Sell
23
-5
-18% -$3.95K ﹤0.01% 2196
2017
Q2
$24K Hold
28
﹤0.01% 2225
2017
Q1
$19K Hold
28
﹤0.01% 2189
2016
Q4
$20K Hold
28
﹤0.01% 2224
2016
Q3
$26K Buy
28
+27
+2,700% +$34.1K ﹤0.01% 2228
2016
Q2
$1K Hold
1
﹤0.01% 2294
2016
Q1
$1K Hold
1
﹤0.01% 2281
2015
Q4
$1K Hold
1
﹤0.01% 2292
2015
Q3
$1K Sell
1
-1
-50% -$1.93K ﹤0.01% 2301
2015
Q2
$4K Hold
2
﹤0.01% 2400
2015
Q1
$5K Hold
2
﹤0.01% 2313
2014
Q4
$6K Hold
2
﹤0.01% 2261
2014
Q3
$6K Hold
2
﹤0.01% 2252
2014
Q2
$9K Hold
2
﹤0.01% 2288
2014
Q1
$10K Hold
2
﹤0.01% 2274
2013
Q4
$9K Hold
2
﹤0.01% 2140
2013
Q3
$10K Hold
2
﹤0.01% 2257
2013
Q2
$24K Buy
+2
New +$22.2K ﹤0.01% 2153

Other funds holding FRTX

Panagora Asset Management's FRTX Position: Q1 2020 in Review

Panagora Asset Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2020, closing a stake of 1 share.

Panagora Asset Management first reported a position in FRTX in Q2 2013 and held it in 27 quarters. The position peaked at $223K in Q3 2018. 14 funds tracked by Wall St. Rank hold FRTX as of Q1 2020.

  • Panagora Asset Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Panagora Asset Management sold 1 Fresh Tracks Therapeutics, Inc. Common Stock share in Q1 2020.
  • Panagora Asset Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
  • Panagora Asset Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $223K in Q3 2018.
  • 14 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Panagora Asset Management's 13F filing for Q1 2020, filed 14 May 2020.